敗血症診斷市場規模、佔有率和成長分析（按技術、應用、產品、方法、病原體類型、檢測類型、最終用戶和地區）—2025-2032 年產業預測

2023 年敗血症診斷市場規模價值 6.9 億美元，預計將從 2024 年的 7.5 億美元成長到 2032 年的 14.6 億美元，預測期間（2025-2032 年）的複合年成長率為 8.7%。

由於老年人和免疫力缺乏等高風險族群中感染疾病相關住院人數不斷增加，敗血症診斷市場已成為醫療保健領域的重要領域。多重檢測和快速 PCR 檢測等技術進步正在提高檢測的速度和準確性，而監管措施正在推動敗血症管理的改善。儘管具有這種潛在的成長，但由於特異性症狀導致的敗血症診斷的複雜性以及診斷測試成本的上升等挑戰，限制了其在資源受限環境中的使用。此外，多樣化的測試協議和標準化的需求可能會阻礙創新技術的採用。然而，在新生物標記的開發、快速檢測解決方案、人工智慧和機器學習的整合以及協作研發工作中仍存在機會。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 次要和主要資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024 年）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析

敗血症診斷市場規模（依技術及複合年成長率） (2025-2032)

• 市場概況
• 血液培養技術

敗血症診斷市場規模（按應用和複合年成長率）（2025-2032）

• 市場概況
• 醫院
• 診斷中心

敗血症診斷市場規模（按產品和複合年成長率） (2025-2032)

• 市場概況
• 血培養基
• 檢測試劑組
• 裝置
• 軟體

敗血症診斷市場規模（依方法和複合年成長率） (2025-2032)

• 市場概況
• 常規診斷
• 自動診斷

敗血症診斷市場規模（按病原體類型和複合年成長率）（2025-2032）

• 市場概況
• 細菌性敗血症
  • 革蘭氏陰性菌膿毒症
  • 革蘭氏陽性細菌性膿毒症真菌性膿毒症
• 其他病原體類型

敗血症診斷市場規模（按測試類型和複合年成長率） (2025-2032)

• 市場概況
• 實驗室測試
• 就地檢驗

敗血症診斷市場規模（按最終用戶和複合年成長率） (2025-2032)

• 市場概況
• 醫院和專科診所
• 病理學和參考實驗室
• 研究部門
• 學術機構

敗血症診斷市場規模（按地區）及複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前 5 家公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採用的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024 年）
• 主要企業簡介
  • 公司詳細資訊
  • 產品系列分析
  • 公司分部佔有率分析
  • 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

• BioMerieux SA（France）
• Becton, Dickinson and Company（BD）（USA）
• Thermo Fisher Scientific, Inc.（USA）
• F. Hoffmann-La Roche AG（Switzerland）
• Danaher Corporation（Beckman Coulter, Inc.）（USA）
• Bruker Corporation（USA）
• Abbott Laboratories, Inc.（USA）
• Cepheid（USA）
• Luminex Corporation（USA）
• T2 Biosystems, Inc.（USA）
• Siemens Healthineers（Germany）
• Qiagen NV（Netherlands）
• Immunexpress, Inc.（USA）
• Seegene Inc.（South Korea）
• Koninklijke Philips NV（Netherlands）
• GenMark Diagnostics（USA）
• Wolters Kluwer NV.（Netherlands）
• Epic Systems Corporation.（USA）
• McKesson Corporation.（USA）

結論和建議

Sepsis Diagnostics Market size was valued at USD 0.69 billion in 2023 and is poised to grow from USD 0.75 billion in 2024 to USD 1.46 billion by 2032, growing at a CAGR of 8.7% during the forecast period (2025-2032).

The sepsis diagnostics market is a crucial segment of the healthcare sector, driven by rising infection-related hospitalizations among high-risk populations, including the elderly and immunocompromised individuals. Technological advancements such as multiplex assays and rapid PCR tests are enhancing detection speed and accuracy, while regulatory initiatives are fostering improved sepsis management practices. Despite this growth potential, challenges such as high diagnostic test costs limit accessibility in resource-constrained settings, alongside the complexity of sepsis diagnosis due to its non-specific symptoms. Additionally, varying testing protocols and the need for standardization may hinder the adoption of innovative technologies. However, opportunities exist in the development of new biomarkers, rapid testing solutions, and the integration of AI and machine learning, along with collaborative research and development efforts.

Top-down and bottom-up approaches were used to estimate and validate the size of the Sepsis Diagnostics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Sepsis Diagnostics Market Segments Analysis

Global Sepsis Diagnostics Market is segmented by Technology, Application, Product, Method, Pathogen Type, Test Type, End Users and region. Based on Technology, the market is segmented into Blood Culture Technology. Based on Application, the market is segmented into Hospitals and Diagnostics Centres. Based on Product, the market is segmented into Blood Culture Media, Assays and Reagent Kits, Instruments and Software. Based on Method, the market is segmented into Conventional Diagnostics and Automated Diagnostics. Based on Pathogen Type, the market is segmented into Bacterial Sepsis and Other Pathogen Types. Based on Test Type, the market is segmented into Laboratory Tests and Point-Of-Care Tests. Based on End Users, the market is segmented into Hospitals And Speciality Clinics, Pathology and Reference Laboratories, Research Laboratories and Academic Institute. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Sepsis Diagnostics Market

The Sepsis Diagnostics market is significantly driven by the rising awareness and training initiatives aimed at healthcare professionals, emphasizing the importance of early sepsis detection and management. This growing focus is leading to a higher uptake of diagnostic tests and related services. Additionally, there has been a surge in public education campaigns highlighting the symptoms and signs of sepsis, which encourages individuals to seek timely medical attention. As a result, this proactive approach not only fosters prompt diagnosis but also enhances testing frequencies, further stimulating the overall growth of the Sepsis Diagnostics market.

Restraints in the Sepsis Diagnostics Market

The Sepsis Diagnostics market faces significant challenges due to the diverse and non-specific signs and symptoms associated with sepsis, which complicate early diagnosis. This complexity can lead to delays in treatment or misdiagnosis, undermining the effectiveness of diagnostic tools. Furthermore, accurate sepsis diagnosis often requires a combination of tests, which adds to the complexity and extends the turnaround time for results. This protracted process can hamper patient outcomes and diminish the perceived value of diagnostic solutions, ultimately restraining the growth and development of the Sepsis Diagnostics market. Addressing these issues is crucial for improving diagnostic efficiency and market expansion.

Market Trends of the Sepsis Diagnostics Market

The Sepsis Diagnostics market is witnessing a significant trend towards the adoption of advanced molecular diagnostic techniques, particularly next-generation sequencing (NGS) and polymerase chain reaction (PCR). These methodologies are revolutionizing pathogen detection by providing accurate and rapid results, drastically reducing the time for diagnosis compared to traditional culture methods. This shift is critical in sepsis management, as early intervention greatly enhances patient outcomes. As healthcare providers increasingly prioritize timely diagnostics, the demand for these innovative technologies is surging, positioning them as essential components in combating sepsis and driving overall market growth. The focus on precision medicine further amplifies this trend, promising enhanced efficacy in treatment protocols.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Sepsis Diagnostics Market Size by Technology & CAGR (2025-2032)

• Market Overview
• Blood Culture Technology

Global Sepsis Diagnostics Market Size by Application & CAGR (2025-2032)

• Market Overview
• Hospitals
• Diagnostics Centres

Global Sepsis Diagnostics Market Size by Product & CAGR (2025-2032)

• Market Overview
• Blood Culture Media
• Assays and Reagent Kits
• Instruments
• Software

Global Sepsis Diagnostics Market Size by Method & CAGR (2025-2032)

• Market Overview
• Conventional Diagnostics
• Automated Diagnostics

Global Sepsis Diagnostics Market Size by Pathogen Type & CAGR (2025-2032)

• Market Overview
• Bacterial Sepsis
  • Gram-Negative Bacterial Sepsis
  • Gram-Positive Bacterial Sepsis Fungal Sepsis
• Other Pathogen Types

Global Sepsis Diagnostics Market Size by Test Type & CAGR (2025-2032)

• Market Overview
• Laboratory Tests
• Point-Of-Care Tests

Global Sepsis Diagnostics Market Size by End Users & CAGR (2025-2032)

• Market Overview
• Hospitals And Speciality Clinics
• Pathology and Reference Laboratories
• Research Laboratories
• Academic Institute

Global Sepsis Diagnostics Market Size & CAGR (2025-2032)

• North America (Technology, Application, Product, Method, Pathogen Type, Test Type, End Users)
  • US
  • Canada
• Europe (Technology, Application, Product, Method, Pathogen Type, Test Type, End Users)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Technology, Application, Product, Method, Pathogen Type, Test Type, End Users)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Technology, Application, Product, Method, Pathogen Type, Test Type, End Users)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Technology, Application, Product, Method, Pathogen Type, Test Type, End Users)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• BioMerieux SA (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (BD) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (Beckman Coulter, Inc.) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bruker Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cepheid (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Luminex Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• T2 Biosystems, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Qiagen N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Immunexpress, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Seegene Inc. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Koninklijke Philips N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GenMark Diagnostics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Wolters Kluwer NV. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Epic Systems Corporation. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• McKesson Corporation. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations